Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.

Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN.

Radiology. 2005 May;235(2):469-77.

PMID:
15858089
2.

Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.

Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Torchillin VP, Halpern EF, Kruskal JB.

Radiology. 2002 Mar;222(3):797-804.

PMID:
11867804
3.

Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.

Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, Goldberg SN.

J Vasc Interv Radiol. 2005 Oct;16(10):1365-71.

PMID:
16221908
4.

Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model.

Monsky WL, Kruskal JB, Lukyanov AN, Girnun GD, Ahmed M, Gazelle GS, Huertas JC, Stuart KE, Torchilin VP, Goldberg SN.

Radiology. 2002 Sep;224(3):823-9.

PMID:
12202721
5.

Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.

Head HW, Dodd GD 3rd, Bao A, Soundararajan A, Garcia-Rojas X, Prihoda TJ, McManus LM, Goins BA, Santoyo CA, Phillips WT.

Radiology. 2010 May;255(2):405-14. doi: 10.1148/radiol.10090714.

6.

Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?

Yang W, Ahmed M, Elian M, Hady el-SA, Levchenko TS, Sawant RR, Signoretti S, Collins M, Torchilin VP, Goldberg SN.

Radiology. 2010 Dec;257(3):685-96. doi: 10.1148/radiol.10100500. Epub 2010 Sep 21.

7.

Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.

Goldberg SN, Saldinger PF, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Kruskal JB.

Radiology. 2001 Aug;220(2):420-7.

PMID:
11477246
8.

Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.

Ahmed M, Monsky WE, Girnun G, Lukyanov A, D'Ippolito G, Kruskal JB, Stuart KE, Torchilin VP, Goldberg SN.

Cancer Res. 2003 Oct 1;63(19):6327-33.

9.

Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.

Soundararajan A, Dodd GD 3rd, Bao A, Phillips WT, McManus LM, Prihoda TJ, Goins BA.

Radiology. 2011 Dec;261(3):813-23. doi: 10.1148/radiol.11110361. Epub 2011 Oct 24.

10.

RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.

Solazzo S, Mertyna P, Peddi H, Ahmed M, Horkan C, Goldberg SN.

Int J Hyperthermia. 2008 Nov;24(7):560-7. doi: 10.1080/02656730802070768.

PMID:
18608584
11.

Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.

D'Ippolito G, Ahmed M, Girnun GD, Stuart KE, Kruskal JB, Halpern EF, Goldberg SN.

Radiology. 2003 Jul;228(1):112-8. Epub 2003 Jun 13.

PMID:
12808127
12.

Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model.

Ahmed M, Liu Z, Afzal KS, Weeks D, Lobo SM, Kruskal JB, Lenkinski RE, Goldberg SN.

Radiology. 2004 Mar;230(3):761-7.

PMID:
14990840
13.

Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model.

Ahmed M, Weinstein J, Liu Z, Afzal KS, Horkan C, Kruskal JB, Goldberg SN.

J Vasc Interv Radiol. 2003 Aug;14(8):1045-52.

PMID:
12902563
14.

Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.

Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Torchilin V, Goldberg SN.

J Control Release. 2012 Jun 10;160(2):239-44. doi: 10.1016/j.jconrel.2011.12.031. Epub 2011 Dec 30.

15.

Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.

Moussa M, Goldberg SN, Tasawwar B, Sawant RR, Levchenko T, Kumar G, Torchilin VP, Ahmed M.

J Vasc Interv Radiol. 2013 Jul;24(7):1021-33. doi: 10.1016/j.jvir.2013.03.006. Epub 2013 May 9.

16.

Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model.

Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Collins M, Signoretti S, Torchilin V, Goldberg SN.

Int J Hyperthermia. 2011;27(6):527-38. doi: 10.3109/02656736.2011.582474.

17.

Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.

Mostafa EM, Ganguli S, Faintuch S, Mertyna P, Goldberg SN.

J Vasc Interv Radiol. 2008 Dec;19(12):1740-8. doi: 10.1016/j.jvir.2008.08.028. Epub 2008 Oct 31.

PMID:
18951042
18.

Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways.

Solazzo SA, Ahmed M, Schor-Bardach R, Yang W, Girnun GD, Rahmanuddin S, Levchenko T, Signoretti S, Spitz DR, Torchilin V, Goldberg SN.

Radiology. 2010 Apr;255(1):62-74. doi: 10.1148/radiol.09091196. Epub 2010 Feb 16.

19.

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.

Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN.

Radiology. 2006 Jul;240(1):82-9. Epub 2006 May 23.

PMID:
16720872
20.

Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model.

Ahmed M, Lobo SM, Weinstein J, Kruskal JB, Gazelle GS, Halpern EF, Afzal SK, Lenkinski RE, Goldberg SN.

J Vasc Interv Radiol. 2002 Jul;13(7):717-24.

PMID:
12119331
Items per page

Supplemental Content

Write to the Help Desk